Difference between revisions of "Team:BIT/Prize"
WANGWENJIA (Talk | contribs) |
Xiangzifan (Talk | contribs) |
||
| (56 intermediate revisions by 3 users not shown) | |||
| Line 59: | Line 59: | ||
<div class="col-xs-10 text-right menu-1"> | <div class="col-xs-10 text-right menu-1"> | ||
<ul> | <ul> | ||
| − | + | ||
<li class="has-dropdown"> | <li class="has-dropdown"> | ||
| − | <a | + | <a>Project</a> |
<ul class="dropdown"> | <ul class="dropdown"> | ||
| − | <li><a href="https://2017.igem.org/Team:BIT/ | + | <li><a href="https://2017.igem.org/Team:BIT/Design">Design</a></li> |
| − | <li><a href="2017.igem.org/Team:BIT/ | + | <li><a href="https://2017.igem.org/Team:BIT/Demonstrate">Demonstrate</a></li> |
<li><a href="https://2017.igem.org/Team:BIT/Model">Model</a></li> | <li><a href="https://2017.igem.org/Team:BIT/Model">Model</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
| − | <li><a href=" | + | <li class="has-dropdown"> |
| − | + | <a href="https://2017.igem.org/Team:BIT/achievement">Achievement</a> | |
| − | <li><a href=" | + | <ul class="dropdown"> |
| − | <li class="btn-cta"><a href=" | + | <li><a href="https://2017.igem.org/Team:BIT/Medal">Medal</a></li> |
| + | <li><a href="https://2017.igem.org/Team:BIT/Prize">Prize</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Parts">Part</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Safety">Safety Form</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
| + | |||
| + | <li class="has-dropdown"> | ||
| + | <a href="https://2017.igem.org/Team:BIT/HP">Practice</a> | ||
| + | <ul class="dropdown"> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/HP/Silver">Silver</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/HP/Gold_Integrated">Gold</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Engagement"> Engagement</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Entrepreneurship">Entreperneurship</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
| + | <li class="has-dropdown"> | ||
| + | <a href="https://2017.igem.org/Team:BIT/Notebook">Notebook</a> | ||
| + | <ul class="dropdown"> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Gallery">Gallery</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Track">Track</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/nb">Journal</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Protocol">Protocol</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
| + | <li class="has-dropdown"> | ||
| + | <a href="https://2017.igem.org/Team:BIT/Team">Team</a> | ||
| + | <ul class="dropdown"> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Collaborations">Collaborations</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Team/Member">Member</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Attribution">Attribution</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
| + | <li class="btn-cta"><a href="https://2017.igem.org/Team:BIT"><span>Home</span></a></li> | ||
</ul> | </ul> | ||
</div> | </div> | ||
| Line 85: | Line 118: | ||
<body> | <body> | ||
<div class="my-banner" id="top"> | <div class="my-banner" id="top"> | ||
| − | <center><img src="https://static.igem.org/mediawiki/2017/ | + | <center><img src="https://static.igem.org/mediawiki/2017/3/3f/Bit_figure_prize_lllll.png" alt=""><center> |
</div> | </div> | ||
<section class="content_container" id="mytop"> | <section class="content_container" id="mytop"> | ||
<div class="section-upline cd-section" id="Bronze"> | <div class="section-upline cd-section" id="Bronze"> | ||
| − | <h1 class="title-h1"><center>Prize<center></h1> | + | <h1 class="title-h1"><center>Prize</center></h1> |
| + | |||
| + | <section class="content_container" id="mytop"> | ||
| + | <div class="section-upline cd-section" id="Bronze"> | ||
| + | |||
| + | <h3 class="title-h3"><center>This year Team BIT makes great efforts and have a try to make the project be realized on demonstrate. In the meanwhile we have achieved the criterion of five iGEM Prizes : Integrated Human Practices, Education and Public Engagement, Entrepreneurship, Hardware and Best New Composite Part. Now here are the details for these Prizes.<center></h3> | ||
| + | |||
| + | |||
<div class="row"><!--row --> | <div class="row"><!--row --> | ||
| Line 99: | Line 139: | ||
<div class="row"> | <div class="row"> | ||
| − | <div class="col-xs-12"> | + | |
| − | <img src="https://static.igem.org/mediawiki/ | + | <div class="col-xs-12"> |
| + | <img src="https://static.igem.org/mediawiki/2017/5/51/Prize_bit_figure.png" class="img-responsive img-center" alt="Bronze"> | ||
</div> | </div> | ||
| − | + | ||
| + | |||
| + | <div class="col-xs-12"> | ||
<div class="row"> | <div class="row"> | ||
| Line 110: | Line 153: | ||
<img src="https://static.igem.org/mediawiki/2016/5/55/T--Technion_Israel--Checked.png" class="img-responsive" align="right" alt="Bronze" width="20"> | <img src="https://static.igem.org/mediawiki/2016/5/55/T--Technion_Israel--Checked.png" class="img-responsive" align="right" alt="Bronze" width="20"> | ||
</div> | </div> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| + | |||
| + | |||
| + | |||
<div class="col-xs-10"> | <div class="col-xs-10"> | ||
<p class="text-left"> | <p class="text-left"> | ||
| − | + | Based on JACOB, iGEM_BIT opened a platform at China Science and Technology Museum for ordinary communities to understand synthetic biology and microfluidic chip. And a survey had been made to over 300 foreigners. We also discussed with middle students deeply and visited three industries and two healthcare centers for our project.For details please refer to Wiki Page.<a href="https://2017.igem.org/Team:BIT/Engagement" >Click Here</a> to see the Engagement. | |
</p> | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
</div> | </div> | ||
</div> | </div> | ||
| Line 181: | Line 181: | ||
<div class="col-xs-12"> | <div class="col-xs-12"> | ||
| − | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2017/8/85/Prize_bit_figure2.png" class="img-responsive img-center" alt="Bronze"> |
</div> | </div> | ||
| Line 187: | Line 187: | ||
<div class="row"> | <div class="row"> | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
<div class="row"> | <div class="row"> | ||
| Line 215: | Line 195: | ||
<div class="col-xs-10"> | <div class="col-xs-10"> | ||
<p class="text-left"> | <p class="text-left"> | ||
| − | <a href="https://2017.igem.org/Team:BIT/HP/ | + | JACOB is offering a new interaction between healthcare and patients, which allows treatments to be concentrated on early detection and precaution. It will improve the cure rate and be a financial relief, so that less conflicts will arise between patients and hospitals. These advantages make JACOB an awesome tool.<a href="https://2017.igem.org/Team:BIT/HP/Gold_Integrated" >Click Here</a> to see the HP/Gold_Integrated. |
</p> | </p> | ||
</div> | </div> | ||
| Line 231: | Line 211: | ||
<div class="col-xs-12"> | <div class="col-xs-12"> | ||
| − | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2017/b/b4/Prize_bit_figure3333.png" class="img-responsive img-center" alt="Bronze"> |
</div> | </div> | ||
| Line 240: | Line 220: | ||
<div class="col-xs-2"> | <div class="col-xs-2"> | ||
<img src="https://static.igem.org/mediawiki/2016/5/55/T--Technion_Israel--Checked.png" class="img-responsive" align="right" alt="Bronze" width="20"> | <img src="https://static.igem.org/mediawiki/2016/5/55/T--Technion_Israel--Checked.png" class="img-responsive" align="right" alt="Bronze" width="20"> | ||
| − | </div> | + | </div></div></div> |
<div class="col-xs-10"> | <div class="col-xs-10"> | ||
<p class="text-left"> | <p class="text-left"> | ||
| − | + | JACOB’s portability, efficiency and accessibility are built upon effectual inter-disciplinary applications of synthetic biology and hardware engineering. It can simplify the sample inputs, recognize GFP and RFP simultaneously and sustain a consistent environment for host bacteria E.coli. Overall, JACOB’s core is a creative and evolvable artboard for future practices.<a href=" https://2017.igem.org/Team:BIT/Hardware " target="_blank">Click Here</a>. | |
| − | + | ||
</p> | </p> | ||
| Line 250: | Line 230: | ||
</div> | </div> | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
</div> | </div> | ||
| Line 278: | Line 239: | ||
<br> | <br> | ||
<br> | <br> | ||
| + | |||
| + | |||
| + | |||
<br> | <br> | ||
| − | + | <div class="row"><!--row --> | |
<div class="col-sm-10 col-sm-offset-1"><!-- 10/12 --> | <div class="col-sm-10 col-sm-offset-1"><!-- 10/12 --> | ||
<div class="row"> | <div class="row"> | ||
| Line 287: | Line 251: | ||
<div class="col-xs-12"> | <div class="col-xs-12"> | ||
| − | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2017/d/de/Prize_bit_figure3884.png" class="img-responsive img-center" alt="Bronze"> |
</div> | </div> | ||
| Line 299: | Line 263: | ||
<div class="col-xs-10"> | <div class="col-xs-10"> | ||
<p class="text-left"> | <p class="text-left"> | ||
| − | + | We recharacterized JACOB commercially based on investigations of the market and process of industrialization, in perspectives of consumers, commercial companies, and hospitals. There is a big market of household-level warning-diagnostic tools for serious diseases, just like JACOB. We are currently planning to resolve mass productions jointly cooperating with other institutes or capitals.<a href="https://2017.igem.org/Team:BIT/Entrepreneurship" >Click Here</a> to see the Entrepreneurship. </p> | |
| − | + | ||
| − | + | ||
</div> | </div> | ||
</div> | </div> | ||
| − | <div class="row"> | + | |
| − | + | </div> | |
| − | + | </div> | |
| − | + | </div> | |
| − | + | </div> | |
| − | + | ||
| − | + | <!--====================================--> | |
| − | + | ||
| − | + | <div class="col-sm-4 col-xs-12"> | |
| − | + | <div class="row"> | |
| + | |||
| + | <div class="col-xs-12"> | ||
| + | <img src="https://static.igem.org/mediawiki/2017/7/7d/Prize_bit_figure388423213.png" class="img-responsive img-center" alt="Bronze"> | ||
| + | </div> | ||
| + | |||
| + | <div class="col-xs-12"> | ||
| + | <div class="row"> | ||
| + | |||
| + | |||
<div class="row"> | <div class="row"> | ||
| Line 322: | Line 293: | ||
<div class="col-xs-10"> | <div class="col-xs-10"> | ||
<p class="text-left"> | <p class="text-left"> | ||
| − | + | We modified and refined the previous part: <a href="http://parts.igem.org/Part:BBa_J37032" >J37032</a>, and created our new part: <a href="http://parts.igem.org/Part:BBa_K2305004" >K2305004</a>,its' fluorescent expression was eighty times higher than the previous part.Here is the link to the<a href=" https://2017.igem.org/Team:BIT/Composite_Part " target="_blank"> Composite_Part</a>. | |
</p> | </p> | ||
</div> | </div> | ||
| − | </div> | + | </div> |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
</div> | </div> | ||
</div> | </div> | ||
| Line 368: | Line 309: | ||
<div class="col-xs-12"> | <div class="col-xs-12"> | ||
| − | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2017/a/a1/Bit_figure_timu.jpeg" class="img-responsive img-center" alt="Bronze"> |
</div> | </div> | ||
| Line 377: | Line 318: | ||
<div class="col-xs-2"> | <div class="col-xs-2"> | ||
<img src="https://static.igem.org/mediawiki/2016/5/55/T--Technion_Israel--Checked.png" class="img-responsive" align="right" alt="Bronze" width="20"> | <img src="https://static.igem.org/mediawiki/2016/5/55/T--Technion_Israel--Checked.png" class="img-responsive" align="right" alt="Bronze" width="20"> | ||
| − | </div> | + | </div></div> |
<div class="col-xs-10"> | <div class="col-xs-10"> | ||
<p class="text-left"> | <p class="text-left"> | ||
| − | + | To facilitate early diagnosis, we contrived a biosensor of onset-pathological biomarkers with high sensitivity, affordability, and analyte modifiability. Here are three highlights: first, biosensor (aptamer) is able to be artificially designed aimed at target biomarker; second, bioamplifier (gene knock-out, strong promoter, cycle amplifier and dual-fluorescence) realizes improvement of signal to noise ratio; third, micro-fluidic chip and fluorescence detector make it possible that the assay can work in practical.<a href=" https://2017.igem.org/Team:BIT " target="_blank">READ MORE.</a> | |
| + | |||
| + | </p> | ||
</p> | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
</div> | </div> | ||
| Line 411: | Line 334: | ||
</div> | </div> | ||
</div> | </div> | ||
| − | + | </div> | |
| − | < | + | |
| − | + | <br> | |
| + | <br> | ||
| Line 420: | Line 344: | ||
<!--以下是页脚 --> | <!--以下是页脚 --> | ||
</footer> | </footer> | ||
| − | <div id="fh5co-started"> | + | <div id="fh5co-started"> |
| − | + | <div class="overlay"></div> | |
| − | + | <div class="container"> | |
| − | + | <div class="row animate-box"> | |
| − | + | <div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | |
| − | + | <h2>Contact Us!</h2> | |
| − | + | <p><center>Please keep reading if you want to contact us.</center></p> | |
| − | + | ||
| − | + | </div> | |
| − | + | </div> | |
| − | + | </div> | |
| + | </div> | ||
| + | <footer id="fh5co-footer" role="contentinfo"> | ||
| + | <div class="container"> | ||
| + | <div class="row row-pb-md"> | ||
| + | <div class="col-md-4 fh5co-widget"> | ||
| + | <h4>BIT</h4> | ||
| + | <p>It's an excellent Team with thoughtful persons full of funs to the academic</p> | ||
| + | </div> | ||
| + | <div class="col-md-2 col-md-push-1 fh5co-widget"> | ||
| + | <h4>Links</h4> | ||
| + | <ul class="fh5co-footer-links"> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT">Home</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Team">Team</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/achievement">Achievement</a></li> | ||
| + | <li><a href="https://2017.igem.org/Team:BIT/Notebook">Notebook</a></li> | ||
| + | </ul> | ||
| + | </div> | ||
| + | |||
| + | <div class="col-md-4 col-md-push-1 fh5co-widget"> | ||
| + | <h4>Contact Information</h4> | ||
| + | <ul class="fh5co-footer-links"> | ||
| + | <li><a href="">Beijing Institute of Technology No.5 Yard,Zhong Guan Cun South Street Haidian District, Beijing, CHINA</li> | ||
| + | <li><a href="">Wechat:iGEM_BIT</a></li> | ||
| + | <li><a href="">igem_bit@outlook.com</a></li> | ||
| + | <li><a href="">Facebook:iGEM_BIT</li> | ||
| + | </ul> | ||
| + | </div> | ||
| + | </div> | ||
| + | <div class="row copyright"> </div> | ||
| + | </div> | ||
| + | </footer> | ||
</div> | </div> | ||
| − | + | <div class="gototop js-top"> <a href="#" class="js-gotop"><i class="icon-arrow-up22"></i></a> </div> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
<!-- JS FILES --> | <!-- JS FILES --> | ||
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js?action=raw&ctype=text/jacascript"></script> | <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js?action=raw&ctype=text/jacascript"></script> | ||
<script src="https://2017.igem.org/Template:BIT/bootstrap/min/Javascript"></script> | <script src="https://2017.igem.org/Template:BIT/bootstrap/min/Javascript"></script> | ||
| − | |||
<script src="https://2017.igem.org/Template:BIT/jquery/flexslider-min/Javascript"></script> | <script src="https://2017.igem.org/Template:BIT/jquery/flexslider-min/Javascript"></script> | ||
| − | + | <script src="https://2017.igem.org/Template:BIT/jquery.easing/1/3/Javascript?action=raw&ctype=text/javascript"></script> | |
| − | + | <!-- Bootstrap --> | |
| − | <script src="https://2017.igem.org/Template:BIT/jquery.easing/1/3/Javascript?action=raw&ctype=text/javascript"></script> | + | <script src="https://2017.igem.org/Template:BIT/bootstrap/Javascript?action=raw&ctype=text/javascript"></script> |
| − | + | <!-- Waypoints --> | |
| − | <script src="https://2017.igem.org/Template:BIT/bootstrap/Javascript?action=raw&ctype=text/javascript"></script> | + | <script src="https://2017.igem.org/Template:BIT/jquery/waypoints/min/Javascript?action=raw&ctype=text/javascript"></script> |
| − | + | <!-- Flexslider --> | |
| − | <script src="https://2017.igem.org/Template:BIT/jquery/waypoints/min/Javascript?action=raw&ctype=text/javascript"></script> | + | <script src="https://2017.igem.org/Template:BIT/jquery/flexslider-min/Javascript?action=raw&ctype=text/javascript"></script> |
| − | + | <!-- Main --> | |
| − | <script src="https://2017.igem.org/Template:BIT/jquery/flexslider-min/Javascript?action=raw&ctype=text/javascript"></script> | + | |
| − | + | ||
<script src="https://2017.igem.org/Template:BIT/main/Javascript?action=raw&ctype=text/javascript"></script> | <script src="https://2017.igem.org/Template:BIT/main/Javascript?action=raw&ctype=text/javascript"></script> | ||
| − | + | </body> | |
| − | + | ||
</html> | </html> | ||
Latest revision as of 02:58, 2 November 2017
Prize
This year Team BIT makes great efforts and have a try to make the project be realized on demonstrate. In the meanwhile we have achieved the criterion of five iGEM Prizes : Integrated Human Practices, Education and Public Engagement, Entrepreneurship, Hardware and Best New Composite Part. Now here are the details for these Prizes.
Based on JACOB, iGEM_BIT opened a platform at China Science and Technology Museum for ordinary communities to understand synthetic biology and microfluidic chip. And a survey had been made to over 300 foreigners. We also discussed with middle students deeply and visited three industries and two healthcare centers for our project.For details please refer to Wiki Page.Click Here to see the Engagement.
JACOB is offering a new interaction between healthcare and patients, which allows treatments to be concentrated on early detection and precaution. It will improve the cure rate and be a financial relief, so that less conflicts will arise between patients and hospitals. These advantages make JACOB an awesome tool.Click Here to see the HP/Gold_Integrated.
JACOB’s portability, efficiency and accessibility are built upon effectual inter-disciplinary applications of synthetic biology and hardware engineering. It can simplify the sample inputs, recognize GFP and RFP simultaneously and sustain a consistent environment for host bacteria E.coli. Overall, JACOB’s core is a creative and evolvable artboard for future practices.Click Here.
We recharacterized JACOB commercially based on investigations of the market and process of industrialization, in perspectives of consumers, commercial companies, and hospitals. There is a big market of household-level warning-diagnostic tools for serious diseases, just like JACOB. We are currently planning to resolve mass productions jointly cooperating with other institutes or capitals.Click Here to see the Entrepreneurship.
We modified and refined the previous part: J37032, and created our new part: K2305004,its' fluorescent expression was eighty times higher than the previous part.Here is the link to the Composite_Part.
To facilitate early diagnosis, we contrived a biosensor of onset-pathological biomarkers with high sensitivity, affordability, and analyte modifiability. Here are three highlights: first, biosensor (aptamer) is able to be artificially designed aimed at target biomarker; second, bioamplifier (gene knock-out, strong promoter, cycle amplifier and dual-fluorescence) realizes improvement of signal to noise ratio; third, micro-fluidic chip and fluorescence detector make it possible that the assay can work in practical.READ MORE.
Contact Us!
